What Biomarkers Can Reveal About Breast Cancer
 

As cancer researchers move away from the general use of chemotherapy and into more targeted approaches, scientists are working to discover effective ways to measure response and risk. Data presented at the CTRC-AACR San Antonio Breast Cancer Symposium illustrate the cutting edge of biomarker discovery and development. Reductions in Breast Density Predict Potential Benefit of Tamoxifen Abstract #61, Jack Cuzick, Ph.D.

More...